Markus Tarköy

Nessuna posizione attualmente

Health Technology

Consumer Services

Commercial Services

Profilo

Markus Tarköy worked as a Principal at Berna Biotech AG and as President at Swiss Federal Institute of Technology.
He also worked as Head-Process Development at Kenta Biotech AG from 2010 to 2013.
Dr. Tarköy received his undergraduate and doctorate degrees from Swiss Federal Institute of Technology.

Precedenti posizioni note di Markus Tarköy

Società	Posizione	Fine
Kenta Biotech AG Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland.	Corporate Officer/Principal	01/01/2013
Swiss Federal Institute of Technology	Presidente	-
Berna Biotech AG Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Markus Tarköy

Formazione di Markus Tarköy

Swiss Federal Institute of Technology

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Markus Tarköy

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Kenta Biotech AG Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland.	Health Technology
Berna Biotech AG Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland	Commercial Services